208 related articles for article (PubMed ID: 30536640)
1. Risk of skin cancer in psoriasis patients receiving long-term narrowband ultraviolet phototherapy: Results from a Taiwanese population-based cohort study.
Lin TL; Wu CY; Chang YT; Juan CK; Chen CC; Yu SH; Chen YJ
Photodermatol Photoimmunol Photomed; 2019 May; 35(3):164-171. PubMed ID: 30536640
[TBL] [Abstract][Full Text] [Related]
2. Methotrexate did not add skin cancer risk in patients with psoriasis receiving narrowband ultraviolet B phototherapy: a nationwide retrospective cohort study.
Chao CH; Wu CY; Chou FL; Chen YJ
Clin Exp Dermatol; 2024 Apr; 49(5):459-465. PubMed ID: 38056487
[TBL] [Abstract][Full Text] [Related]
3. Frequency of skin cancer among psoriasis, vitiligo, and mycosis fungoides patients treated with narrowband ultraviolet B phototherapy.
Mimouni I; Shulman J; Unes AA; Pavlovsky L; Pavlotsky F
Photodermatol Photoimmunol Photomed; 2024 Jan; 40(1):e12936. PubMed ID: 38059681
[TBL] [Abstract][Full Text] [Related]
4. Incidence of skin malignancies in patients with vitiligo or psoriasis who received narrowband ultraviolet B phototherapy (308 nm/311 nm): A retrospective review of 3730 patients.
Chia BKY; Yew YW; Zhao X; Chong WS; Thng TGS
Photodermatol Photoimmunol Photomed; 2023 Jul; 39(4):343-350. PubMed ID: 36345565
[TBL] [Abstract][Full Text] [Related]
5. A cross-sectional analysis of skin cancer risk in patients receiving narrow-band ultraviolet B phototherapy: an evaluation of 100 patients.
Karaosmanoglu N; Ozdemir Cetinkaya P; Kutlu O; Karaaslan E; Imren IG; Kiratli Nalbant E; Eksioglu M
Arch Dermatol Res; 2020 May; 312(4):249-253. PubMed ID: 31729594
[TBL] [Abstract][Full Text] [Related]
6. Carcinogenic risks of psoralen UV-A therapy and narrowband UV-B therapy in chronic plaque psoriasis: a systematic literature review.
Archier E; Devaux S; Castela E; Gallini A; Aubin F; Le Maître M; Aractingi S; Bachelez H; Cribier B; Joly P; Jullien D; Misery L; Paul C; Ortonne JP; Richard MA
J Eur Acad Dermatol Venereol; 2012 May; 26 Suppl 3():22-31. PubMed ID: 22512677
[TBL] [Abstract][Full Text] [Related]
7. Incidence of skin cancers in 3867 patients treated with narrow-band ultraviolet B phototherapy.
Hearn RM; Kerr AC; Rahim KF; Ferguson J; Dawe RS
Br J Dermatol; 2008 Sep; 159(4):931-5. PubMed ID: 18834483
[TBL] [Abstract][Full Text] [Related]
8. No evidence for increased skin cancer risk in psoriasis patients treated with broadband or narrowband UVB phototherapy: a first retrospective study.
Weischer M; Blum A; Eberhard F; Röcken M; Berneburg M
Acta Derm Venereol; 2004; 84(5):370-4. PubMed ID: 15370703
[TBL] [Abstract][Full Text] [Related]
9. [Narrow-band UVB therapy in psoriasis vulgaris: good practice guideline and recommendations of the French Society of Photodermatology].
Beani JC; Jeanmougin M
Ann Dermatol Venereol; 2010 Jan; 137(1):21-31. PubMed ID: 20110064
[TBL] [Abstract][Full Text] [Related]
10. Serum 5-S-cysteinyldopa levels in patients with psoriasis undergoing narrowband ultraviolet B phototherapy.
Kikuchi K; Wakamatsu K; Tada Y; Komine M; Ito S; Tamaki K
Clin Exp Dermatol; 2008 Nov; 33(6):750-3. PubMed ID: 18954414
[TBL] [Abstract][Full Text] [Related]
11. Serum 25-hydroxyvitamin D increases with NB-UVB and UVA/UVB phototherapy in patients with psoriasis and atopic dermatitis in Western Australia.
Le P; Tu J; Gebauer K; Brown S
Australas J Dermatol; 2016 May; 57(2):115-21. PubMed ID: 25916422
[TBL] [Abstract][Full Text] [Related]
12. Incidence and profile of skin cancers in patients following ultraviolet phototherapy without psoralens: A retrospective cohort study.
Wang E; Ahad T; Liu YA; Lee TK; Lui H; Crawford RI; Kalia S
J Am Acad Dermatol; 2024 Apr; 90(4):759-766. PubMed ID: 38070541
[TBL] [Abstract][Full Text] [Related]
13. The challenge of follow-up in narrowband ultraviolet B phototherapy.
Diffey BL; Farr PM
Br J Dermatol; 2007 Aug; 157(2):344-9. PubMed ID: 17553037
[TBL] [Abstract][Full Text] [Related]
14. Predictors of adherence to Narrowband ultraviolet B first-month treatment dosage plan.
Pavlotsky F; Alkhazov A; Barzilai A; Scope A
Isr Med Assoc J; 2022 Dec; 25(12):820-823. PubMed ID: 36573776
[TBL] [Abstract][Full Text] [Related]
15. Could colorimetric method replace the individual minimal erythemal dose (MED) measurements in determining the initial dose of narrow-band UVB treatment for psoriasis patients with skin phototype III-V?
Kwon IH; Kwon HH; Na SJ; Youn JI
J Eur Acad Dermatol Venereol; 2013 Apr; 27(4):494-8. PubMed ID: 22340091
[TBL] [Abstract][Full Text] [Related]
16. A randomized, observer-blinded trial of twice vs. three times weekly narrowband ultraviolet B phototherapy for chronic plaque psoriasis.
Cameron H; Dawe RS; Yule S; Murphy J; Ibbotson SH; Ferguson J
Br J Dermatol; 2002 Nov; 147(5):973-8. PubMed ID: 12410709
[TBL] [Abstract][Full Text] [Related]
17. A randomized comparison of selective broadband UVB and narrowband UVB in the treatment of psoriasis.
Kirke SM; Lowder S; Lloyd JJ; Diffey BL; Matthews JN; Farr PM
J Invest Dermatol; 2007 Jul; 127(7):1641-6. PubMed ID: 17380117
[TBL] [Abstract][Full Text] [Related]
18. Ultraviolet B Phototherapy for Psoriasis: Review of Practical Guidelines.
Mehta D; Lim HW
Am J Clin Dermatol; 2016 Apr; 17(2):125-33. PubMed ID: 26872953
[TBL] [Abstract][Full Text] [Related]
19. Methotrexate plus narrowband UVB phototherapy versus narrowband UVB phototherapy alone in the treatment of plaque-type psoriasis: a randomized, placebo-controlled study.
Asawanonda P; Nateetongrungsak Y
J Am Acad Dermatol; 2006 Jun; 54(6):1013-8. PubMed ID: 16713455
[TBL] [Abstract][Full Text] [Related]
20. Topical 8-methoxypsoralen enhances the therapeutic results of targeted narrowband ultraviolet B phototherapy for plaque-type psoriasis.
Asawanonda P; Amornpinyokeit N; Nimnuan C
J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):50-5. PubMed ID: 18181973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
